136 related articles for article (PubMed ID: 37097663)
1. Tumor DNA in Peritoneal Lavage as a Novel Biomarker for Predicting Peritoneal Recurrence in Patients With Gastric Cancer.
Yukawa N; Yamada T; Aoyama T; Woo T; Ueda K; Mastuda A; Hara K; Kazama K; Tamagawa H; Sato T; Oshima T; Suzuki A; Aburatani H; Ishikawa S; Saito A; Masuda M; Yoshida H; Rino Y
Anticancer Res; 2023 May; 43(5):2069-2076. PubMed ID: 37097663
[TBL] [Abstract][Full Text] [Related]
2. Peritoneal Lavage Tumor DNA as a Novel Biomarker for Predicting Peritoneal Recurrence in Pancreatic Ductal Adenocarcinoma.
Suenaga M; Fujii T; Yamada S; Hayashi M; Shinjo K; Takami H; Niwa Y; Sonohara F; Shimizu D; Kanda M; Kobayashi D; Tanaka C; Nakayama G; Koike M; Fujiwara M; Kondo Y; Kodera Y
Ann Surg Oncol; 2021 Apr; 28(4):2277-2286. PubMed ID: 32875467
[TBL] [Abstract][Full Text] [Related]
3. Peritoneal Tumor DNA as a Prognostic Biomarker in Gastric Cancer: A Systematic Review and Meta-Analysis.
Allan Z; Witts S; Wong DJ; Lee MM; Tie J; Tebbutt NC; Clemons NJ; Liu DS
JCO Precis Oncol; 2024 Mar; 8():e2300546. PubMed ID: 38513167
[TBL] [Abstract][Full Text] [Related]
4. Improving diagnostic accuracy of identifying gastric cancer patients with peritoneal metastases: tumor-guided cell-free DNA analysis of peritoneal fluid.
van der Sluis K; van Sandick JW; Vollebergh MA; van Dieren JM; Hugen N; Hartemink KJ; Veenhof AAFA; Verhoeven E; van den Berg JG; Snaebjornsson P; Noe M; van Wezel T; Boelens MC; Kodach LL
Oncogene; 2024 Jun; 43(24):1877-1882. PubMed ID: 38654110
[TBL] [Abstract][Full Text] [Related]
5. [Application of laparoscopic exploration combined with abdominal exfoliative cytology in the diagnosis and treatment of locally advanced gastric cancer].
Ding PA; Liu Y; Guo HH; Yang PG; Tian Y; Fan LQ; Tan BB; Li Y; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):170-176. PubMed ID: 32074798
[No Abstract] [Full Text] [Related]
6. Prospective study to validate the clinical utility of DNA diagnosis of peritoneal fluid cytology test in gastric cancer.
Harada H; Soeno T; Nishizawa N; Washio M; Sakuraya M; Ushiku H; Niihara M; Hosoda K; Kumamoto Y; Naitoh T; Sangai T; Hiki N; Yamashita K
Cancer Sci; 2021 Apr; 112(4):1644-1654. PubMed ID: 33576114
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of cytological status of peritoneal lavage fluid during intraperitoneal chemotherapy for gastric cancer with overt peritoneal dissemination.
Emoto S; Kitayama J; Ishigami H; Yamaguchi H; Watanabe T
Ann Surg Oncol; 2015 Mar; 22(3):780-6. PubMed ID: 25216603
[TBL] [Abstract][Full Text] [Related]
8. Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival with advanced gastric cancer with positive cytology test.
Yamashita K; Ushiku H; Katada N; Hosoda K; Moriya H; Mieno H; Kikuchi S; Hoshi K; Watanabe M
Eur J Surg Oncol; 2015 Oct; 41(10):1324-32. PubMed ID: 26251341
[TBL] [Abstract][Full Text] [Related]
9. The utility of pre-operative peritoneal lavage examination in serosa-invading gastric cancer patients.
Makino T; Fujiwara Y; Takiguchi S; Miyata H; Yamasaki M; Nakajima K; Nishida T; Mori M; Doki Y
Surgery; 2010 Jul; 148(1):96-102. PubMed ID: 20096433
[TBL] [Abstract][Full Text] [Related]
10. Significance of Intraperitoneal-free
Kaku H; Aoyagi K; Sudo T; Tanaka Y; Minami T; Isobe T; Kizaki J; Umetani Y; Murakami N; Fujita F; Akagi Y
Anticancer Res; 2022 Aug; 42(8):4003-4010. PubMed ID: 35896219
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of intraperitoneal CD44 mRNA levels of magnetically separated CD45-negative EpCAM-positive cells for peritoneal recurrence and prognosis in stage II and III gastric cancer patients.
Horikawa M; Iinuma H; Inoue T; Ogawa E; Fukushima R
Oncol Rep; 2011 May; 25(5):1413-20. PubMed ID: 21331451
[TBL] [Abstract][Full Text] [Related]
12. Detection of minimal gastric cancer cells in peritoneal washings by focused microarray analysis with multiple markers: clinical implications.
Mori K; Suzuki T; Uozaki H; Nakanishi H; Ueda T; Matsuno Y; Kodera Y; Sakamoto H; Yamamoto N; Sasako M; Kaminishi M; Sasaki H
Ann Surg Oncol; 2007 May; 14(5):1694-702. PubMed ID: 17294072
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of positive cases with peritoneal lavage cytology in gastric cancer].
Yamamoto M; Mashino K; Shibahara K; Oki E; Kakeji Y; Baba H; Maehara Y
Gan To Kagaku Ryoho; 2005 Oct; 32(10):1389-92. PubMed ID: 16227735
[TBL] [Abstract][Full Text] [Related]
14. Quantitative molecular diagnosis of peritoneal lavage fluid for prediction of peritoneal recurrence in gastric cancer.
Sugita Y; Fujiwara Y; Taniguchi H; Mori T; Ishii T; Niwa H; Okada Y; Takiguchi S; Yasuda T; Yano M; Monden M
Int J Oncol; 2003 Nov; 23(5):1419-23. PubMed ID: 14532985
[TBL] [Abstract][Full Text] [Related]
15. Peritoneal cytology in the surgical evaluation of gastric carcinoma.
Hayes N; Wayman J; Wadehra V; Scott DJ; Raimes SA; Griffin SM
Br J Cancer; 1999 Feb; 79(3-4):520-4. PubMed ID: 10027323
[TBL] [Abstract][Full Text] [Related]
16. Impact of preoperative chemotherapy as initial treatment for advanced gastric cancer with peritoneal metastasis limited to positive peritoneal lavage cytology (CY1) or localized peritoneal metastasis (P1a): a multi-institutional retrospective study.
Yamaguchi T; Takashima A; Nagashima K; Terashima M; Aizawa M; Ohashi M; Tanaka R; Yamada T; Kinoshita T; Matsushita H; Ishiyama K; Hosoda K; Yuasa Y; Haruta S; Kakihara N; Nishikawa K; Yunome G; Satoh T; Fukagawa T; Katai H; Boku N
Gastric Cancer; 2021 May; 24(3):701-709. PubMed ID: 33179192
[TBL] [Abstract][Full Text] [Related]
17. Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer.
Tokuhisa M; Ichikawa Y; Kosaka N; Ochiya T; Yashiro M; Hirakawa K; Kosaka T; Makino H; Akiyama H; Kunisaki C; Endo I
PLoS One; 2015; 10(7):e0130472. PubMed ID: 26208314
[TBL] [Abstract][Full Text] [Related]
18. Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma.
Bando E; Yonemura Y; Takeshita Y; Taniguchi K; Yasui T; Yoshimitsu Y; Fushida S; Fujimura T; Nishimura G; Miwa K
Am J Surg; 1999 Sep; 178(3):256-62. PubMed ID: 10527450
[TBL] [Abstract][Full Text] [Related]
19. The prognostic impact of peritoneal tumour DNA in gastrointestinal and gynaecological malignancies: a systematic review.
Allan Z; Witts S; Tie J; Tebbutt N; Clemons NJ; Liu DS
Br J Cancer; 2023 Nov; 129(11):1717-1726. PubMed ID: 37700064
[TBL] [Abstract][Full Text] [Related]
20. The levels of SYT13 and CEA mRNAs in peritoneal lavages predict the peritoneal recurrence of gastric cancer.
Nakanishi K; Kanda M; Umeda S; Tanaka C; Kobayashi D; Hayashi M; Yamada S; Kodera Y
Gastric Cancer; 2019 Nov; 22(6):1143-1152. PubMed ID: 31055693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
